Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
825 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01519089 | A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis | completed | Phase 3 | 95 | PfizerINDUSTRY | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01574235 | Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents | completed | — | 2,114 | Hospira, now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 28, 2015 |
| clinicaltrials |
| NCT02158169 | Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and Haematology(SYNERGY) | completed | — | 2,167 | Hospira, now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 28, 2015 | clinicaltrials |
| NCT01627990 | Nivestim™ in Treatment of Malignant Diseases | completed | — | 386 | Hospira, now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 24, 2015 | clinicaltrials |
| NCT00599924 | Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors | completed | Phase 1 | 53 | PfizerINDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT00136955 | Irinotecan Study For Cervical Cancer | completed | Phase 2 | 41 | PfizerINDUSTRY | 1 | Jun 19, 2015 | clinicaltrials |
| NCT00038311 | Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia | completed | Phase 3 | 120 | PfizerINDUSTRY | 1 | May 4, 2015 | clinicaltrials |
| NCT00471159 | A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer. | withdrawn | Phase 2 | 0 | PfizerINDUSTRY | 0 | May 4, 2015 | clinicaltrials |
| NCT00678626 | Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer | withdrawn | Phase 2 | 0 | PfizerINDUSTRY | 0 | May 4, 2015 | clinicaltrials |
| NCT01827254 | Sutent Rechallenge In mRCC Patients(RESUME) | completed | — | 61 | PfizerINDUSTRY | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00117598 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)(OPTIMAL) | completed | Phase 3 | 169 | PfizerINDUSTRY | 18 | Mar 30, 2015 | clinicaltrials |
| NCT00226811 | An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy | completed | Phase 2 | 78 | PfizerINDUSTRY | 7 | Mar 30, 2015 | clinicaltrials |
| NCT00254891 | Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer | terminated | Phase 3 | 828 | PfizerINDUSTRY | 26 | Mar 30, 2015 | clinicaltrials |
| NCT00254904 | Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC | terminated | Phase 3 | 839 | PfizerINDUSTRY | 24 | Mar 30, 2015 | clinicaltrials |
| NCT00457691 | Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 768 | PfizerINDUSTRY | 34 | Mar 30, 2015 | clinicaltrials |
| NCT00553696 | Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer | completed | Phase 1 | 27 | PfizerINDUSTRY | 1 | Mar 13, 2015 | clinicaltrials |
| NCT00635245 | CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery | withdrawn | Phase 1 | 0 | PfizerINDUSTRY | 0 | Mar 11, 2015 | clinicaltrials |
| NCT01225510 | A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma | withdrawn | Phase 2 | 0 | PfizerINDUSTRY | 0 | Mar 11, 2015 | clinicaltrials |
| NCT00879684 | Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors | completed | Phase 1 | 34 | PfizerINDUSTRY | 1 | Jan 26, 2015 | clinicaltrials |
| NCT02297425 | A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer | withdrawn | Phase 2 | 0 | PfizerINDUSTRY | 0 | Jan 12, 2015 | clinicaltrials |
| NCT01276639 | A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis | completed | Phase 3 | 901 | PfizerINDUSTRY | 11 | Sep 19, 2014 | clinicaltrials |
| NCT01309737 | A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | completed | Phase 3 | 960 | PfizerINDUSTRY | 11 | Sep 19, 2014 | clinicaltrials |
| NCT02031991 | A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01) | completed | Phase 1 | 102 | PfizerINDUSTRY | 1 | Aug 15, 2014 | clinicaltrials |
| NCT00927823 | A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients | completed | Phase 1 | 37 | PfizerINDUSTRY | 1 | Aug 12, 2014 | clinicaltrials |
| NCT01430585 | Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer | terminated | Phase 2 | 14 | PfizerINDUSTRY | 4 | Aug 12, 2014 | clinicaltrials |
| NCT01121562 | Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors | completed | Phase 2 | 12 | PfizerINDUSTRY | 1 | Jun 30, 2014 | clinicaltrials |
| NCT02058277 | A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers | completed | Phase 1 | 20 | PfizerINDUSTRY | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00907504 | Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer(ADVIGO1017) | withdrawn | Phase 3 | 0 | PfizerINDUSTRY | 0 | Jun 17, 2014 | clinicaltrials |
| NCT00729833 | Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors | terminated | Phase 1 | 45 | PfizerINDUSTRY | 1 | Jun 9, 2014 | clinicaltrials |
| NCT01473043 | Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment | no longer available | — | — | PfizerINDUSTRY | 2 | May 30, 2014 | clinicaltrials |
| NCT00038467 | Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer(IES) | completed | Phase 3 | 4,740 | PfizerINDUSTRY | 37 | May 7, 2014 | clinicaltrials |
| NCT00915278 | A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors | terminated | Phase 1 | 33 | PfizerINDUSTRY | 2 | Apr 4, 2014 | clinicaltrials |
| NCT01229436 | Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)(POINT X) | completed | Phase 3 | 254 | PfizerINDUSTRY | 8 | Mar 17, 2014 | clinicaltrials |
| NCT01322633 | Risk of Cancer Among Pantoprazole Users | completed | — | 61,864 | PfizerINDUSTRY | 0 | Feb 20, 2014 | clinicaltrials |
| NCT01121549 | A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer | terminated | — | 378 | PfizerINDUSTRY | 1 | Jan 22, 2014 | clinicaltrials |
| NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | terminated | Phase 3 | 681 | PfizerINDUSTRY | 26 | Jan 13, 2014 | clinicaltrials |
| NCT00836745 | Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent | completed | — | 36 | PfizerINDUSTRY | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00474760 | Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors | completed | Phase 1 | 65 | PfizerINDUSTRY | 2 | Dec 17, 2013 | clinicaltrials |
| NCT00976508 | Figitumumab Combined With Pegvisomant For Advanced Solid Tumors | terminated | Phase 1 | 24 | PfizerINDUSTRY | 4 | Dec 13, 2013 | clinicaltrials |
| NCT00460603 | Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 187 | PfizerINDUSTRY | 1 | Dec 6, 2013 | clinicaltrials |
| NCT00842244 | Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer | completed | Phase 1 | 22 | PfizerINDUSTRY | 2 | Nov 27, 2013 | clinicaltrials |
| NCT00389441 | Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer | completed | Phase 2 | 52 | PfizerINDUSTRY | 9 | Nov 25, 2013 | clinicaltrials |
| NCT00474786 | Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib(INTORSECT) | completed | Phase 3 | 512 | PfizerINDUSTRY | 20 | Nov 21, 2013 | clinicaltrials |
| NCT00776659 | An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin | terminated | — | 39 | PfizerINDUSTRY | 1 | Nov 19, 2013 | clinicaltrials |
| NCT00600821 | A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. | completed | Phase 2 | 118 | PfizerINDUSTRY | 6 | Nov 8, 2013 | clinicaltrials |
| NCT00147537 | Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer | completed | Phase 1 / Phase 2 | 282 | PfizerINDUSTRY | 4 | Oct 30, 2013 | clinicaltrials |
| NCT01653158 | CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies | completed | Phase 1 | 46 | PfizerINDUSTRY | 1 | Oct 30, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials